Cudraflavanone B Isolated from the Root Bark of Cudrania Tricuspidata Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Downregulating NF-κB and ERK MAPK Signaling Pathways in RAW264.7 Macrophages and BV2 Microglia

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2020 Aug 9

PMID 32766955

Citations 9

Authors

Wonmin Ko

Kwan-Woo Kim

Tran Hong Quang

Chi-Su Yoon

Nayeon Kim

Hwan Lee

Sam-Cheol Kim

Eun-Rhan Woo

Youn-Chul Kim

Hyuncheol Oh

Dong-Sung Lee

Affiliations

Soon will be listed here.

Abstract

A prenylated flavonoid, cudraflavanone B, is isolated from Cudrania tricuspidata. In this study, we investigated its anti-inflammatory and anti-neuroinflammatory effects in lipopolysaccharide (LPS)-induced RAW264.7 and BV2 cells. In our initial study of the anti-inflammatory effects of cudraflavanone B the production of nitric oxide and prostaglandin E2 was attenuated in LPS-stimulated RAW264.7 and BV2 cells. These inhibitory effects were related to the downregulation of inducible nitric oxide synthase and cyclooxygenase-2. In addition, cudraflavanone B suppressed the production of pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor-α in LPS-induced RAW264.7 and BV2 cells. Moreover, the evaluation of the molecular mechanisms underlying the anti-inflammatory effects of cudraflavanone B revealed that the compound attenuated the nuclear factor-kappa B signaling pathway in LPS-induced RAW264.7 and BV2 cells. In addition, cudraflavanone B inhibited the phosphorylation of extracellular signal-regulated kinase mitogen-activated protein kinase signaling pathways in these LPS-stimulated cells. Thus, cudraflavanone B suppressed nuclear factor-κB, and extracellular signal-regulated kinase mitogen-activated protein kinase mediated inflammatory pathways, demonstrating its potential in the treatment of neuroinflammatory conditions.

Citing Articles

A Pair of Epimers of Lignan Alleviate Neuroinflammatory Effects by Modulating iNOS/COX-2 and MAPK/NF-κB Signaling Pathways.

Wang F, Wen H, Liu L, Aisa H, Xin X Inflammation. 2024; 48(1):361-371.

PMID: 38878150 DOI: 10.1007/s10753-024-02080-9.

Changes in structural plasticity of hippocampal neurons in an animal model of multiple sclerosis.

Weerasinghe-Mudiyanselage P, Kang S, Kim J, Kim S, Wang H, Shin T Zool Res. 2024; 45(2):398-414.

PMID: 38485508 PMC: 11017077. DOI: 10.24272/j.issn.2095-8137.2023.309.

Phytochemistry and pharmacology of natural prenylated flavonoids.

Lv H, Wang Q, Luo M, Zhu M, Liang H, Li W Arch Pharm Res. 2023; 46(4):207-272.

PMID: 37055613 PMC: 10101826. DOI: 10.1007/s12272-023-01443-4.

Diverse Galactooligosaccharides Differentially Reduce LPS-Induced Inflammation in Macrophages.

Sun C, Hao B, Pang D, Li Q, Li E, Yang Q Foods. 2022; 11(24).

PMID: 36553716 PMC: 9777761. DOI: 10.3390/foods11243973.

An Update on the Multifaceted Role of NF-kappaB in Endometriosis.

Liu Y, Wang J, Zhang X Int J Biol Sci. 2022; 18(11):4400-4413.

PMID: 35864971 PMC: 9295070. DOI: 10.7150/ijbs.72707.

References

Liang D, Li F, Fu Y, Cao Y, Song X, Wang T . Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells. Inflammation. 2013; 37(1):214-22. DOI: 10.1007/s10753-013-9732-x. View

Wang X, Tang S, Wang R, Qiu Y, Jin M, Kong D . Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells. Inflammation. 2014; 38(3):941-8. DOI: 10.1007/s10753-014-0056-2. View

Ahn C, Jung W, Park S, Kim Y, Kim W, Je J . Gallic Acid-g-Chitosan Modulates Inflammatory Responses in LPS-Stimulated RAW264.7 Cells Via NF-κB, AP-1, and MAPK Pathways. Inflammation. 2015; 39(1):366-374. DOI: 10.1007/s10753-015-0258-2. View

Cho S, Yang J, Seo K, Shin S, Park E, Cho S . Extract and Its Major Constituents Inhibit Oxidative Stress-Induced Liver Injury. J Med Food. 2019; 22(6):602-613. DOI: 10.1089/jmf.2018.4322. View

You Y, Min S, Lee Y, Hwang K, Jun W . Hepatoprotective effect of 10% ethanolic extract from Curdrania tricuspidata leaves against ethanol-induced oxidative stress through suppression of CYP2E1. Food Chem Toxicol. 2017; 108(Pt A):298-304. DOI: 10.1016/j.fct.2017.08.007. View

Lee E, Yun H, Lee S, Yoo W . Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-stimulated osteoclast differentiation through downregulation of MAPKs, c-Fos and NFATc1. Korean J Intern Med. 2010; 25(1):93-100. PMC: 2829423. DOI: 10.3904/kjim.2010.25.1.93. View

Kwon S, Kim M, Yang J, Lee H, Hong J, Jeong H . Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells. PLoS One. 2016; 11(3):e0150235. PMC: 4784787. DOI: 10.1371/journal.pone.0150235. View

Nam S, Jang H, Shibamoto T . Antioxidant activities of extracts from teas prepared from medicinal plants, Morus alba L., Camellia sinensis L., and Cudrania tricuspidata , and their volatile components. J Agric Food Chem. 2012; 60(36):9097-105. DOI: 10.1021/jf301800x. View

Kim D, Lee S, Chung Y, Kim B, Kim H, Kim K . Antiobesity and Antidiabetes Effects of a Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential. Biomed Res Int. 2016; 2016:8432759. PMC: 4775776. DOI: 10.1155/2016/8432759. View

10.

Chang S, Jung E, Lim D, Oyungerel B, Lim K, Her E . Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation. J Pharm Pharmacol. 2008; 60(9):1221-6. DOI: 10.1211/jpp.60.9.0015. View

11.

Kwon J, Tuan Hiep N, Kim D, Hong S, Guo Y, Hwang B . Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects. J Nat Prod. 2016; 79(8):1938-51. DOI: 10.1021/acs.jnatprod.6b00204. View

12.

Shim J, Lim K . Inhibitory effect of glycoprotein isolated from Cudrania tricuspidata bureau on expression of inflammation-related cytokine in bisphenol A-treated HMC-1 cells. Inflammation. 2009; 32(4):211-7. DOI: 10.1007/s10753-009-9122-6. View

13.

Yoon C, Kim D, Quang T, Seo J, Kang D, Lee H . A Prenylated Xanthone, Cudratricusxanthone A, Isolated from Cudrania tricuspidata Inhibits Lipopolysaccharide-Induced Neuroinflammation through Inhibition of NF-κB and p38 MAPK Pathways in BV2 Microglia. Molecules. 2016; 21(9). PMC: 6272989. DOI: 10.3390/molecules21091240. View

14.

Rho Y, Lee B, Park K, Bae Y . Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells, at least in part, through the inhibition of DNA topoisomerase I and protein kinase C activity. Anticancer Drugs. 2007; 18(9):1023-8. DOI: 10.1097/CAD.0b013e3281de7264. View

15.

Kim K, Quang T, Ko W, Kim D, Yoon C, Oh H . Anti-neuroinflammatory effects of cudraflavanone A isolated from the chloroform fraction of Cudrania tricuspidata root bark. Pharm Biol. 2018; 56(1):192-200. PMC: 6130620. DOI: 10.1080/13880209.2018.1447972. View

16.

Oh P, Lim K . Anti-inflammatory effect of glycoprotein isolated from Cudrania tricuspidata Bureau: involvement of MAPK/NF-κB signaling. Immunol Invest. 2010; 40(1):76-91. DOI: 10.3109/08820139.2010.516049. View

17.

Fukai T, Yonekawa M, Hou A, Nomura T, Sun H, Uno J . Antifungal agents from the roots of Cudrania cochinchinensis against Candida, Cryptococcus, and Aspergillus species. J Nat Prod. 2003; 66(8):1118-20. DOI: 10.1021/np030024u. View

18.

Quang T, Ngan N, Yoon C, Cho K, Kang D, Lee H . Protein Tyrosine Phosphatase 1B Inhibitors from the Roots of Cudrania tricuspidata. Molecules. 2015; 20(6):11173-83. PMC: 6272669. DOI: 10.3390/molecules200611173. View

19.

Ko W, Sohn J, Jang J, Ahn J, Kang D, Lee H . Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells. Chem Biol Interact. 2015; 244:16-26. DOI: 10.1016/j.cbi.2015.11.024. View

20.

Titheradge M . The enzymatic measurement of nitrate and nitrite. Methods Mol Biol. 2000; 100:83-91. DOI: 10.1385/1-59259-749-1:83. View